CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Burns James William Chief Legal Officer | Sale 10b5-1 | −1,163 | $28.96 | $34K | 44,086 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 67,608 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 71,593 |
| 2026-03-02 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 74,406 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −594 | $28.96 | $17K | 38,800 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 42,785 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 45,598 |
| 2026-03-02 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −1,573 | $28.96 | $46K | 49,328 |
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,681 | $28.96 | $49K | 38,778 |
| 2026-03-02 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −1,187 | $28.96 | $34K | 41,591 |
| 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −698 | $28.96 | $20K | 2,595 |
| 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −727 | $28.96 | $21K | 4,243 |
| 2026-03-02 | Washburn Theodore James Jr. Principal Accounting Officer | Sale 10b5-1 | −798 | $28.96 | $23K | 6,140 |
| 2026-01-05 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −2,872 | $27.02 | $78K | 34,793 |
| 2025-12-30 | Burns James William Chief Legal Officer | Sale 10b5-1 | −2,932 | $27.09 | $79K | 31,718 |
| 2025-12-30 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −12,473 | $27.09 | $338K | 136,583 |
| 2025-12-30 | Goff Brian Chief Executive Officer | Sale 10b5-1 | −6,230 | $27.09 | $169K | 143,103 |
| 2025-12-30 | Gheuens Sarah Chief Medical Officer | Sale 10b5-1 | −2,932 | $27.09 | $79K | 64,795 |
| 2025-12-30 | Milanova Tsveta Chief Commercial Officer | Sale 10b5-1 | −2,932 | $27.09 | $79K | 29,190 |
| 2025-12-30 | Jones Cecilia Chief Financial Officer | Sale 10b5-1 | −2,932 | $27.09 | $79K | 37,394 |
Page 2 of 31 · 607 trades